---
title: "Clene to present at Canaccord Growth Conference, host investor meetings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294208295.md"
description: "Clene Inc. will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026, at 10:30 a.m. ET. Additionally, company management plans to hold one-on-one investor meetings during the conference."
datetime: "2026-07-29T12:32:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294208295.md)
  - [en](https://longbridge.com/en/news/294208295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294208295.md)
generator: "portal-rs"
---

# Clene to present at Canaccord Growth Conference, host investor meetings

-   Clene will present at the Canaccord 46th Annual Growth Conference in Boston on Aug. 11, 2026 at 10:30 a.m. ET. \* Management will also hold one-on-one investor meetings at the conference. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clene Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607290830PRIMZONEFULLFEED9799623) on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CLNN.US](https://longbridge.com/en/quote/CLNN.US.md)
- [CLNNW.US](https://longbridge.com/en/quote/CLNNW.US.md)

## Related News & Research

- [Clene to Present Corporate Update at Emerging Growth Conference](https://longbridge.com/en/news/296106042.md)
- [Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses](https://longbridge.com/en/news/296405637.md)
- [Kineo Finance to Attend TechBBQ 2026 Conference](https://longbridge.com/en/news/296839531.md)
- [Gosol Energy corrects 2025 balance sheet comparatives; 2026 figures unchanged](https://longbridge.com/en/news/297176578.md)
- [VER: Q2 2026 delivered 6.5% like-for-like revenue growth and strong gross margin, with 2026 guidance reaffirmed](https://longbridge.com/en/news/297124510.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**